Muneer A. Satter, Director, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), bought 120,000 shares at $2.08 ($255K) on 2019-01-03, disclosed to the SEC on 2019-01-07.
Open-market purchase of $255k ARPO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 20,000 | $42K | 16.3% |
| 2 | $2.08 | 20,000 | $42K | 16.3% |
| 3 | $2.12 | 20,000 | $42K | 16.6% |
| 4 | $2.12 | 20,000 | $42K | 16.6% |
| 5 | $2.18 | 20,000 | $44K | 17.1% |
| 6 | $2.18 | 20,000 |
| $44K |
| 17.1% |
| Total | $2.13 avg | 120,000 | $255K | 100% |
| Filing → |
| ANNX | BUY | 2025-11-19 | $5.1M | — | Filing → |
| ANNX | BUY | 2023-12-28 | $1.0M | — | Filing → |
| ANNX | BUY | 2023-02-14 | $36.0M | — | Filing → |